You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HER2/NEU negative

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 Trial in

Suspended
  • Anatomic Stage 0 Breast Cancer AJCC v8
  • +18 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 4, 2022

Stage III Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer Trial in Nashville (Atezolizumab, Cobimetinib,

Terminated
Has Results
  • Stage III Breast Cancer
  • +6 more
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Aug 10, 2021

Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive, HER2/Neu Negative Trial in United States (Anastrozole,

Active, not recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +6 more
  • Atlanta, Georgia
  • +9 more
Oct 12, 2022

Advanced Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Trial in Houston

Recruiting
  • Advanced Breast Carcinoma
  • +14 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 31, 2022

Estrogen Receptor Negative, HER2 Positive Breast Carcinoma, HER2/Neu Negative Trial in United States (External Beam Radiation

Recruiting
  • Estrogen Receptor Negative
  • +11 more
  • External Beam Radiation Therapy
  • +4 more
  • Phoenix, Arizona
  • +7 more
Aug 4, 2021

Inflammatory Breast Cancer, Stage IIA Breast Cancer, Stage IIIA Breast Cancer Trial in Duarte, South Pasadena (carboplatin,

Active, not recruiting
  • Inflammatory Breast Cancer
  • +9 more
  • Duarte, California
  • +1 more
Jul 9, 2021

Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 Trial

Recruiting
  • Anatomic Stage IA Breast Cancer AJCC v8
  • +27 more
  • Aspiration of Breast
  • Biospecimen Collection
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Oct 29, 2021

Breast Tumors, Breast Cancer, Adenocarcinomas Trial run by the NCI (AdHER2/neu DC Vaccine)

Completed
Has Results
  • Breast Neoplasms
  • +3 more
  • Adenoviral Transduced Autologous Human Epidermal Growth Factor Receptor (AdHER)2/neu Dendritic Cell (DC) Vaccine
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 12, 2022

Breast Cancer, HER2-positive Trial in Houston (Zanidatamab, Letrozole, Tamoxifen)

Recruiting
  • Breast Cancer
  • HER2-positive
  • Houston, Texas
    M D Anderson Cancer Center
Jul 9, 2022

HER2/Neu Negative, Progesterone Receptor Negative, Progesterone Receptor Positive Trial in United States (procedure, drug,

Active, not recruiting
  • HER2/Neu Negative
  • +3 more
  • Computed Tomography
  • +3 more
  • Birmingham, Alabama
  • +24 more
Jan 27, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Negative, HER2/Neu Negative Trial in Portland (Durvalumab, Olaparib)

Completed
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +5 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Nov 18, 2020

HER2-low in Unresectable and/or Metastatic Breast Cancer

Not yet recruiting
  • Breast Neoplasms, Breast Cancer, Breast Carcinoma, Genes, HER-2, Genes, HER2
    • (no location specified)
    Nov 6, 2023

    HER2-low in Metastatic Breast Cancer Patients

    Not yet recruiting
    • HER2-negative
      • (no location specified)
      Nov 9, 2023

      Clinical Outcomes in HR+ and HER2-low/Negative Breast Cancer

      Active, not recruiting
      • Hormone-receptor-positive Breast Cancer
      • +2 more
      • No drug
      • Cambridge, Massachusetts
        ConcertAI database
      Sep 8, 2023

      Acute Myeloid Leukemia, Brain Glioblastoma, Estrogen Receptor Negative Trial in Fullerton (Best Practice, Laboratory Biomarker

      Active, not recruiting
      • Acute Myeloid Leukemia
      • +66 more
      • Best Practice
      • +3 more
      • Fullerton, California
        Virginia K Crosson Cancer Center
      Jan 31, 2022

      HER2/Neu Negative, Recurrent Inflammatory Breast Carcinoma, Stage IV Breast Cancer Trial in Chicago (Ipilimumab, Laboratory

      Terminated
      Has Results
      • HER2/Neu Negative
      • +3 more
      • Ipilimumab
      • +2 more
      • Chicago, Illinois
        Northwestern University
      Jun 30, 2020

      Triple Negative Breast Cancer, HER2-positive Breast Cancer Trial in Shanghai (proton plus carbon ion radiotherapy)

      Recruiting
      • Triple Negative Breast Cancer
      • HER2-positive Breast Cancer
      • proton plus carbon ion radiotherapy
      • Shanghai, China
        Shanghai Proton and Heavy Ion center
      Jan 11, 2023

      Breast Cancer Trial in Xi'an (metronomic oral vinorelbine plus anlotinib)

      Recruiting
      • Breast Cancer
      • metronomic oral vinorelbine plus anlotinib
      • Xi'an, Shaanxi, China
        Xi'an International Medical Center Hospital
      Aug 27, 2023

      Breast Cancer Trial in Duarte, Columbus (omega 3 fatty acids)

      Active, not recruiting
      • Breast Cancer
      • omega 3 fatty acids
      • Duarte, California
      • +1 more
      Jun 8, 2022

      Advanced HER2 Negative Breast Carcinoma HRD+Breast Cancer Trial in Guangzhou (Fluzoparib, Fluzoparib+Camrelizumab)

      Recruiting
      • Advanced HER2 Negative Breast Carcinoma HRD+Breast Cancer
      • Guangzhou, Guangdong, China
        Sun-yat sen university cancer center
      Jan 27, 2023

      Breast Cancer Trial in United States (Placebo, GLSI-100)

      Recruiting
      • Breast Cancer
      • Placebo
      • GLSI-100
      • Birmingham, Alabama
      • +21 more
      Jan 30, 2023

      Advanced HR-positive and HER2-negative Breast Cancer; CDK4/6 Inhibitor Treatment Failed Trial in Hangzhou (dalpiciclib;

      Recruiting
      • Advanced HR-positive and HER2-negative Breast Cancer; CDK4/6 Inhibitor Treatment Failed
      • dalpiciclib; fluvestrant; compound gossypol acetate tablets
      • Hangzhou, Zhejiang, China
        zhejiangCH
      Nov 9, 2023

      Breast Cancer Trial in Tianjin (Dalcelli?Exemestane?Gosserine, Docetaxel for injection?Epirubicin HCl for

      Recruiting
      • Breast Cancer
      • Tianjin, Tianjin, China
        Jie Ge
      Aug 20, 2023

      Breast Tumors Trial in Guangzhou (procedure, drug, biological)

      Recruiting
      • Breast Neoplasms
      • Sentinel Lymph Node Biopsy (SLNB)
      • +7 more
      • Guangzhou, Guangdong, China
        Sun Yat-sen Memorial Hospital, Sun Yat-sen University
      Nov 2, 2023

      Breast Tumors Trial in Guangzhou (procedure, drug, biological)

      Recruiting
      • Breast Neoplasms
      • Surgery for harvesting tumor-draining lymph nodes
      • +6 more
      • Guangzhou, Guangdong, China
        Sun Yat-sen Memorial Hospital, Sun Yat-sen University
      Nov 2, 2023